![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 51, 49238-49246, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Medicine, Columbia University,
New York, New York 10032
Production of cytokines is one of the major
mechanisms employed by CD4+ T cells to coordinate
immune responses. Although the molecular mechanisms controlling T cell
cytokine production have been extensively studied, the factors that
endow T cells with their ability to produce unique sets of cytokines
have not been fully characterized. Interferon regulatory factor (IRF)-4
is a lymphoid-restricted member of the interferon regulatory factor
family of transcriptional regulators, whose deficiency leads to a
profound impairment in the ability of mature CD4+ T cells
to produce cytokines. In these studies, we have investigated the
mechanisms employed by IRF-4 to control cytokine synthesis. We
demonstrate that stable expression of IRF-4 in Jurkat T cells not only
leads to a strong enhancement in the synthesis of interleukin (IL)-2, but also enables these cells to start producing considerable amounts of IL-4, IL-10, and IL-13. Transient transfection assays indicate that IRF-4 can transactivate luciferase reporter constructs driven by either the human IL-2 or the human IL-4 promoter. A detailed
analysis of the effects of IRF-4 on the IL-4 promoter reveals that
IRF-4 binds to a site adjacent to a functionally important NFAT binding
element and that IRF-4 cooperates with NFATc1. These studies thus
support the notion that IRF-4 represents one of the lymphoid-specific
components that control the ability of T lymphocytes to produce a
distinctive array of cytokines.
Modulation of T Cell Cytokine Production by Interferon
Regulatory Factor-4*
,
,
*
This work was supported by a grant from the Juvenile
Diabetes Foundation International.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to the work.
This article has been cited by other articles:
![]() |
X. Zhu, M. S. Chang, R. C. Hsueh, R. Taussig, K. D. Smith, M. I. Simon, and S. Choi Dual Ligand Stimulation of RAW 264.7 Cells Uncovers Feedback Mechanisms That Regulate TLR-Mediated Gene Expression J. Immunol., October 1, 2006; 177(7): 4299 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lehtonen, V. Veckman, T. Nikula, R. Lahesmaa, L. Kinnunen, S. Matikainen, and I. Julkunen Differential Expression of IFN Regulatory Factor 4 Gene in Human Monocyte-Derived Dendritic Cells and Macrophages J. Immunol., November 15, 2005; 175(10): 6570 - 6579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Pauleau, R. Rutschman, R. Lang, A. Pernis, S. S. Watowich, and P. J. Murray Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression J. Immunol., June 15, 2004; 172(12): 7565 - 7573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Hogan, L. Chen, J. Nardone, and A. Rao Transcriptional regulation by calcium, calcineurin, and NFAT Genes & Dev., September 15, 2003; 17(18): 2205 - 2232. [Full Text] [PDF] |
||||
![]() |
J. C. Fanzo, C.-M. Hu, S. Y. Jang, and A. B. Pernis Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4) J. Exp. Med., February 3, 2003; 197(3): 303 - 314. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |